Immunogenicity and safety of diphtheria-tetanus vaccine in pre-adolescent and adolescent South Koreans

Vaccine

Volumn 27, Issue 24, 2009, Pages 3209-3212

  Lee, Soo Young ^a   Kwak, Ga Young ^a   Nam, Chan Hee ^a   Kim, Jong Hyun ^a   Hur, Jae Kun ^a   Lee, Kyung Yil ^a   Park, Joon Su ^b   Kim, Hwang Min ^c   Kang, Jin Han ^a  

^a The Catholic University of Korea   (South Korea)

^b Soonchunhyang University   (South Korea)

^c Yonsei University Wonju   (South Korea)

Author keywords

Booster immunization; Diphtheria tetanus vaccine; Safety

Indexed keywords

ANTIBODY; DIPHTHERIA TETANUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIPHTHERIA; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; GROUPS BY AGE; HEADACHE; HUMAN; HUMAN EXPERIMENT; IMMUNOGENICITY; INJECTION SITE PAIN; INJECTION SITE REACTION; INJECTION SITE SWELLING; MALAISE; MALE; MULTICENTER STUDY; NORMAL HUMAN; PHASE 4 CLINICAL TRIAL; PRIORITY JOURNAL; PRURITUS; RESPIRATORY TRACT DISEASE; SCHOOL CHILD; SEROLOGY; SOUTH KOREA; TETANUS; VACCINATION;

ADOLESCENT; CHILD; DIPHTHERIA-TETANUS VACCINE; FEMALE; HUMANS; MALE; VACCINATION;

EID: 67349287570     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.03.037     Document Type: Article

References (20)

1. Turner T.B., Velasco-Joven E.A., and Prudovsky S. Studies on the prophylaxis and treatment of tetanus. II. Studies pertaining to treatment. Bull Johns Hopkins Hosp 102 (1958) 71-84
2. Cain H.D., and Falco F.G. Recurrent tetanus. Calif Med 97 (1962) 31-33
3. Vitek C.R., and Wharton M. Diphtheria toxoid. In: Plotkin S.A., Orenstein W.A., and Offit P.A. (Eds). Vaccines. 5th ed. (2008), WB Saunders Co., Philadelphia 139-156
4. Wassilak S.G.F., Roper M.H., Kretsinger K., and Orenstein W.A. Tetanus toxoid. In: Plotkin S.A., Orenstein W.A., and Offit P.A. (Eds). Vaccines. 5th ed. (2008), WB Saunders Co., Philadelphia 805-840
5. Gergen P.J., McQuillan G.M., Kiely M., Ezzati-Rice T.M., Sutter R.W., and Virella G. A population-based serologic survey of immunity to tetanus in the United States. N Engl J Med 332 (1995) 761-766
6. Broder K.R., Cortese M.M., Iskander J.K., Kretsinger K., Slade B.A., Brown K.H., et al. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 55 RR-3 (2006) 1-34
7. Kang J.H. The need of Td vaccination according to the changes of tetanus and diphtheria Immunity. J Korean Med Assoc 51 (2008) 127-136
8. Kang J.H., Hur J.K., Kim J.H., Lee K.I., Park S.E., Ma S.H., et al. Age related seroepidemiological study of diphtheria among Koreans. Korean J Infect Dis 32 (2000) 1-7
9. Kang J.H., Hur J.K., Kim J.H., Lee K.I., Park S.E., Ma S.H., et al. Age related serosurvey of immunity to tetanus in Korean populations. Korean J Infect Dis 33 (2001) 104-111
10. Shin D.H., Yu H.S., Park J.H., Shin J.H., and Kim S.J. Recently occurring adult tetanus in Korea: emphasis on immunization and awareness of tetanus. J Korean Med Sci 18 (2003) 11-16
11. Yun Y.H., Park H.J., Yu S.W., Kwon S.B., Minn Y.K., Cho S.J., et al. A case of polyneuropathy suggesting diphtheritic neuropathy. J Korean Neurol Assoc 23 (2005) 288-289
12. Relyveld E.H., Bizzini B., and Gupta R.K. Rational approaches to reduce adverse reactions in man to vaccines containing tetanus and diphtheria toxoids. Vaccine 16 (1998) 1016-1023
13. Scheifele D.W., Dobson S., Kallos A., Bjornson G., and Ochnio J.J. Comparative safety of tetanus-diphtheria toxoids booster immunization in students in Grades 6 and 9. Pediatr Infect Dis J 17 (1998) 1121-1126
14. Bayas J.M., Vilella A., Bertran M.J., Vidal J., Batalla J., Asenjo M.A., et al. Immunogenicity and reactogenicity of the adult tetanus-diphtheria vaccine. How many doses are necessary?. Epidemiol Infect 127 (2001) 451-460
15. Vilella A., Dal-Ré R., Simó D., García-Corbeira P., Diego P., and Bayas J.M. Reactogenicity profile of tetanus-diphtheria (adult-type) vaccine: results of a naturalistic study performed at an adult vaccination center. J Clin Pharmacol 40 (2000) 1267-1273
16. Ciofi degli Atti M.L., Salmaso S., Cotter B., Gallo G., Alfarone G., Pinto A., et al. Reactogenicity and immunogenicity of adult versus paediatric diphtheria and tetanus booster dose at 6 years of age. Vaccine 20 (2001) 74-79
17. Mark A., Carlsson R.M., and Granström M. Subcutaneous versus intramuscular injection for booster DT vaccination of adolescents. Vaccine 17 (1999) 2067-2072
18. Blennow M., Granström M., and Strandell A. Adverse reactions after diphtheria-tetanus booster in 10-year-old schoolchildren in relation to the type of vaccine given for the primary vaccination. Vaccine 1 (1994) 427-430
19. Southern J., Andrews N., Burrage M., and Miller E. Immunogenicity and reactogenicity of combined acellular pertussis/tetanus/low dose diphtheria vaccines given as a booster to UK teenagers. Vaccine 23 (2005) 3829-3835
20. Pichichero M.E., Blatter M.M., Kennedy W.A., Hedrick J., Descamps D., and Friedland L.R. Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents. Pediatrics 117 (2006) 1084-1093